The Financial Times has named Paul, Weiss a finalist for “Most Innovative Law Firm in North America” as part of its 2024 Innovative Lawyers North America awards. In addition to the overall most innovative firm recognition, the firm is shortlisted for “Innovative Lawyers in Dispute Resolution,” for our victory against the SEC on behalf of Ripple co-founder and Executive Chairman Chris Larsen, led by litigation partners Martin Flumenbaum and Meredith Dearborn; and for “Innovative Lawyers in Healthcare & Life Sciences,” for advising on Inhibrx’s sale of assets to Sanofi and related spinoff, led by corporate partners Benjamin Goodchild and Krishna Veeraraghavan. The annual awards recognize the most innovative lawyers and law firms leading the legal profession in North America; winners will be announced on December 9.
» see the shortlists